Prostate Cancer - Results from #27380

Editor's Commentary - Dealing with a troublesome body: A qualitative interview study of men's experiences living with prostate cancer treated with endocrine therapy August 2, 2011

Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration - Abstract August 1, 2011

Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling - Abstract August 1, 2011

The use of estramustine phosphate in the modern management of advanced prostate cancer - Abstract August 1, 2011

Oncological and functional outcomes following open radical prostatectomy: How patients may achieve the ″trifecta″? - Abstract August 1, 2011

Biochemical recurrence after radical prostatectomy: Is the disease or the surgeon to blame? - Abstract August 1, 2011

Editor's Commentary - Physical activity after diagnosis and risk of prostate cancer progression: Data from the cancer of the prostate strategic urologic research endeavor August 1, 2011

Prostate cancer diagnostics: Innovative imaging in case of multiple negative biopsies - Abstract July 29, 2011

No association of type-2 diabetes risk variants and prostate cancer risk: The Multiethnic Cohort and PAGE - Abstract July 29, 2011

In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen - Abstract July 29, 2011

Prostatic disease and sexual dysfunction - Abstract July 29, 2011

Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients - Abstract July 29, 2011

Outcomes after prostate brachytherapy are even better than predicted - Abstract July 29, 2011

Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program - Abstract July 29, 2011

Radiotherapy and short-term androgen deprivation for localized prostate cancer - Abstract July 29, 2011

Editor's Commentary - Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment July 29, 2011

Treatment of metastatic bone disease and treatment-induced osteoporosis in prostate cancer : Evolution of osteoprotective strategies - Abstract July 28, 2011

The association of diagnosis in the private or NHS sector on prostate cancer stage and treatment - Abstract July 28, 2011

Emerging treatment options for patients with castration-resistant prostate cancer - Abstract July 28, 2011

Biological significance of perineural invasion (PNI) in prostate cancer - Abstract July 28, 2011

Page 1370 of 1435